These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22387843)

  • 1. International prevalidation study on cell transformation assay. Preface.
    Corvi R; Vanparys P
    Mutat Res; 2012 Apr; 744(1):1-2. PubMed ID: 22387843
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommended protocol for the BALB/c 3T3 cell transformation assay.
    Sasaki K; Bohnenberger S; Hayashi K; Kunkelmann T; Muramatsu D; Phrakonkham P; Poth A; Sakai A; Salovaara S; Tanaka N; Thomas BC; Umeda M
    Mutat Res; 2012 Apr; 744(1):30-5. PubMed ID: 22212201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
    Doktorova TY; Pauwels M; Vinken M; Vanhaecke T; Rogiers V
    Crit Rev Toxicol; 2012 Feb; 42(2):91-106. PubMed ID: 22141324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study.
    Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L; Vanparys P
    Mutat Res; 2012 Apr; 744(1):12-9. PubMed ID: 22138617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays.
    Benigni R; Bossa C; Tcheremenskaia O; Giuliani A
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):809-19. PubMed ID: 20438313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment ILSI/HESI research programme on alternative cancer models: results of Syrian hamster embryo cell transformation assay. International Life Sciences Institute/Health and Environmental Science Institute.
    Farmer PB
    Toxicol Pathol; 2002; 30(4):536-8. PubMed ID: 12187945
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalidation study of the BALB/c 3T3 cell transformation assay for assessment of carcinogenic potential of chemicals.
    Tanaka N; Bohnenberger S; Kunkelmann T; Munaro B; Ponti J; Poth A; Sabbioni E; Sakai A; Salovaara S; Sasaki K; Thomas BC; Umeda M
    Mutat Res; 2012 Apr; 744(1):20-9. PubMed ID: 22198331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay.
    Maire MA; Pant K; Phrakonkham P; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Bohnenberger S; Kunkelmann T; Schulz M; Vasseur P
    Mutat Res; 2012 Apr; 744(1):76-81. PubMed ID: 22198328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro methods and safety testing of chemicals].
    Louekari K; Salminen L; Tähti H
    Duodecim; 1998; 114(9):851-8. PubMed ID: 11524804
    [No Abstract]   [Full Text] [Related]  

  • 10. Photo catalogue for the classification of foci in the BALB/c 3T3 cell transformation assay.
    Sasaki K; Bohnenberger S; Hayashi K; Kunkelmann T; Muramatsu D; Poth A; Sakai A; Salovaara S; Tanaka N; Thomas BC; Umeda M
    Mutat Res; 2012 Apr; 744(1):42-53. PubMed ID: 22331008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals.
    Van Deun K; Van Cauteren H; Vandenberghe J; Canning M; Vanparys P; Coussement W
    Adverse Drug React Toxicol Rev; 1997 Nov; 16(4):215-33. PubMed ID: 9608857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
    Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
    Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed integrated decision-tree testing strategies for mutagenicity and carcinogenicity in relation to the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2007 May; 35(2):267-87. PubMed ID: 17559315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro carcinogenicity testing: present and future perspectives in pharmaceutical development.
    Kowalski LA
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):29-35. PubMed ID: 11727320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
    Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
    Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0 for assessment of carcinogenic potential of chemicals.
    Maire MA; Pant K; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Kunz-Bohnenberger S; Kunkelmann T; Engelhardt G; Schulz M; Vasseur P
    Mutat Res; 2012 Apr; 744(1):64-75. PubMed ID: 22227405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of experimental carcinogenicity studies for human risk assessment.
    Purchase IF
    Int J Exp Pathol; 1991 Dec; 72(6):725-44. PubMed ID: 1768616
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines.
    Sistare FD; Morton D; Alden C; Christensen J; Keller D; Jonghe SD; Storer RD; Reddy MV; Kraynak A; Trela B; Bienvenu JG; Bjurström S; Bosmans V; Brewster D; Colman K; Dominick M; Evans J; Hailey JR; Kinter L; Liu M; Mahrt C; Marien D; Myer J; Perry R; Potenta D; Roth A; Sherratt P; Singer T; Slim R; Soper K; Fransson-Steen R; Stoltz J; Turner O; Turnquist S; van Heerden M; Woicke J; DeGeorge JJ
    Toxicol Pathol; 2011 Jun; 39(4):716-44. PubMed ID: 21666103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of human cell line reporter gene-based assays in chemical toxicity testing.
    Scrivens M; Bhogal N
    Toxicol In Vitro; 2007 Oct; 21(7):1233-40. PubMed ID: 17604594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutat Res; 2010; 705(1):20-39. PubMed ID: 20206292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.